Exploring muscle composition's impact on liver transplant outcomes

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This pilot study investigates the relationship between muscle composition, assessed through MRI-based Muscle Assessment Score (MAsS), and adverse outcomes in candidates for liver transplantation. It focuses on patients with end-stage liver disease, particularly examining the effects of sarcopenia and myosteatosis on transplant success and mortality. By utilizing advanced imaging techniques, the study aims to enhance understanding of body composition's role in liver health and transplant efficacy. The findings could lead to improved patient selection and management strategies for liver transplant candidates.

Why it matters

Who can join: the full rules

Inclusion Criteria:

1. All patients with end-stage liver disease undergoing evaluation for liver transplantation
2. Patient clinically indicated for MRI during transplant candidacy evaluation
3. Adult

Exclusion Criteria:

1\. Contra indication to MRI

Where it's running

• Mayo Clinic Arizona
  Phoenix, Arizona, United States Recruiting

Study contacts

• Principal investigator: Elizabet Carey, MD — Mayo Cinic
• Study coordinator: Latasha Bunkley
• Email: bunkley.latasha@mayo.edu
• Phone: 480.342.5756

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Myokines in metabolic and endocrine diseases linked to sarcopenia

  This study tests whether myokines can serve as biomarkers or drivers of sarcopenia and sarcopenic obesity in people with metabolic or endocrine diseases.

  Recruiting Cliniques universitaires Saint-Luc- Université Catholique de Louvain · Woluwe-Saint-Pierre - Sint-Pieters-Woluwe · NCT07703683

• Even protein distribution plus exercise for people awaiting liver transplant

  This trial tests whether spreading daily protein evenly and combining it with a 12-week exercise program improves nutrition, muscle mass, and function in people waiting for a liver transplant compared with uneven protein timing or usual advice.

  Recruiting at 2 sites Agricultural University of Athens · Athens, Attica and 1 other locations · NCT07561138

• Frailty, Nutrition, and Recovery in People Waiting for a Liver Transplant

  This project will test whether measures of frailty, muscle loss, nutrition, and psychological health can predict outcomes for adults (18–65) on the liver transplant waiting list in Turkey.

  Recruiting Izmir Bakircay University · Izmir · NCT07414095

• TIPS procedure with or without oral branched-chain amino acids (BCAA)

  This test will try giving oral BCAA supplements for three months after TIPS in adults with cirrhosis and sarcopenia to see if it improves muscle and clinical outcomes.

  Recruiting Union Hospital, Tongji Medical College, Huazhong University of Science and Technology · Wuhan · NCT07281846

• Prehab and Creatine/Whey Supplements in Cirrhosis-Related Frailty

  This study tests whether a digital prehabilitation app plus creatine and whey protein can help maintain muscle health in people with cirrhosis and frailty.

  Recruiting University of California, San Francisco · San Francisco, California · NCT07029243

• How TIPS may improve muscle loss in cirrhosis and the role of FGF21

  This project tests whether TIPS helps people with cirrhosis regain muscle and whether blood FGF21 levels explain that improvement.

  Recruiting Union Hospital, Tongji Medical College, Huazhong University of Science and Technology · Wuhan · NCT06794853

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.